Amrize (NYSE:AMRZ) Downgraded by Zacks Research to Strong Sell

Zacks Research downgraded shares of Amrize (NYSE:AMRZ) from a hold rating to a strong sell rating in a report issued on Wednesday morning,Zacks.com reports.

Several other research analysts have also issued reports on AMRZ. JPMorgan Chase & Co. increased their price target on Amrize from $52.00 to $60.00 and gave the stock an “overweight” rating in a report on Tuesday. Royal Bank Of Canada reduced their price target on shares of Amrize from $61.00 to $54.00 and set an “outperform” rating for the company in a research report on Friday, August 8th. Two research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $57.00.

Amrize Trading Up 0.0%

NYSE:AMRZ opened at $51.97 on Wednesday. Amrize has a 52 week low of $44.12 and a 52 week high of $56.29. The company has a quick ratio of 0.85, a current ratio of 1.38 and a debt-to-equity ratio of 0.42.

Amrize (NYSE:AMRZ) last released its earnings results on Wednesday, August 6th. The company reported $0.78 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.03 by ($0.25).

Insider Buying and Selling at Amrize

In other news, CTO Roald Brouwer bought 2,000 shares of the stock in a transaction dated Wednesday, August 27th. The stock was bought at an average price of $51.88 per share, for a total transaction of $103,760.00. Following the completion of the acquisition, the chief technology officer directly owned 5,000 shares in the company, valued at approximately $259,400. This trade represents a 66.67% increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Jaime Hill purchased 4,000 shares of the business’s stock in a transaction that occurred on Friday, August 15th. The shares were purchased at an average price of $51.99 per share, for a total transaction of $207,960.00. Following the completion of the acquisition, the insider owned 13,601 shares of the company’s stock, valued at $707,115.99. The trade was a 41.66% increase in their position. The disclosure for this purchase can be found here. Insiders have purchased a total of 1,124,000 shares of company stock valued at $53,225,260 in the last three months.

Institutional Investors Weigh In On Amrize

Several institutional investors and hedge funds have recently added to or reduced their stakes in AMRZ. BNP Paribas Financial Markets purchased a new position in shares of Amrize in the 2nd quarter worth approximately $59,000. Groupe la Francaise purchased a new position in Amrize in the second quarter worth $60,000. Allianz SE bought a new position in Amrize in the 2nd quarter valued at $80,000. Credit Industriel ET Commercial purchased a new stake in shares of Amrize during the 2nd quarter valued at $109,000. Finally, Westerkirk Capital Inc. purchased a new stake in shares of Amrize during the 2nd quarter valued at $134,000.

Amrize Company Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.